These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 46047

  • 1. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047
    [Abstract] [Full Text] [Related]

  • 2. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov 20; 2(7995):1102-4. PubMed ID: 62946
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep 20; 126(3):460-2. PubMed ID: 6751175
    [Abstract] [Full Text] [Related]

  • 4. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun 20; 129(6):921-8. PubMed ID: 6375490
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan 20; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct 20; 78(4):330-6. PubMed ID: 6386028
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 20; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 20; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 Dec 20; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 12. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
    Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A.
    Am Rev Respir Dis; 1986 Sep 20; 134(3):438-41. PubMed ID: 3530069
    [Abstract] [Full Text] [Related]

  • 13. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug 20; 118(2):219-28. PubMed ID: 100029
    [Abstract] [Full Text] [Related]

  • 14. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr 20; 139(4):871-6. PubMed ID: 2648911
    [Abstract] [Full Text] [Related]

  • 15. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr 20; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [Abstract] [Full Text] [Related]

  • 16. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec 20; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 20; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 18. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V, Catena E, Delli Veneri F, De Michele G, Marra A.
    Am Rev Respir Dis; 1971 Mar 20; 103(3):329-37. PubMed ID: 5005040
    [No Abstract] [Full Text] [Related]

  • 19. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr 20; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [Abstract] [Full Text] [Related]

  • 20. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
    Tubercle; 1977 Mar 20; 58(1):1-8. PubMed ID: 325837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.